The following witnesses gave evidence. Transcripts can be viewed on the inquiry publications page of the Committee’s website.
Professor Paul Riley, British Heart Foundation Professor of Regenerative Medicine, University of Oxford, Professor Stuart Forbes, Professor of Transplantation and Regenerative Medicine, University of Edinburgh, and Professor Peter Andrews, Professor of Biomedical Science, University of Sheffield |
|
Dr Rob Buckle, Director of UK Regenerative Medicine Platform, Research Councils UK, Professor Jeremy Pearson, Associate Medical Director, British Heart Foundation, Professor Neil Hanley, Professor of Medicine, University of Manchester, and Professor Anthony Hollander, Head of Institute of Integrative Biology and Professor of Stem Cell Biology, University of Liverpool |
Dr Ian Hudson, Chief Executive, Medicines and Healthcare products Regulatory Agency, Professor Paul Whiting, Member, Medical Research Council Regenerative Medicine Research Committee, Dr Sven Kili, Head of Gene Therapy Development, GlaxoSmithKline, and Michael Hunt, Chief Financial Officer, ReNeuron Group |
|
Ian Trenholm, Chief Executive, NHS Blood and Transplant, Ian McCubbin, Medicines Manufacturing Industry Partnership and co-chair of the Advanced Therapy Manufacturing Taskforce, Keith Thompson, Chief Executive Officer, Cell and Gene Therapy Catapult, and Dr Ruth McKernan, Chief Executive, Innovate UK |
28 April 2017